Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults

Keyphrases

• Cellular Response 100%
• Humoral Response 100%
• Inactivated SARS-CoV-2 Vaccine 100%
• Second Booster 100%
• COVID-19 83%
• Omicron Variant 83%
• Chile 33%
• CoronaVac 33%
• CD4+ T Lymphocytes 33%
• Flow Cytometry 16%
• Virus 16%
• Fold Increase 16%
• Geometric Mean 16%
• ELISPOT 16%
• Commerce 16%
• Immuno 16%
• Immunology 16%
• CD4+ T Cell Response 16%
• Ministry of Health 16%
• Biotechnology 16%
• COVID-19 Pandemic 16%
• Peripheral Blood Mononuclear Cells 16%
• Phase III Clinical Trial 16%
• Immunogenicity 16%
• Cellular Immunity 16%
• Geometric Mean Titer 16%
• Inactivated Vaccine 16%
• Booster Dose 16%
• SARS-CoV-2 Vaccine 16%
• Neutralizing Responses 16%
• NIAID 16%

Immunology and Microbiology

• Vaccine Efficacy 100%
• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• Omicron Coronavirus Variant 71%
• Neutralization 42%
• CD4+ T Lymphocyte 28%
• Titer 14%
• T-Helper Cell 14%
• Adoptive Immunity 14%
• Intravenous Immunoglobulin 14%
• Immunotherapy 14%
• Immunology 14%
• Mononuclear Cell 14%
• COVID-19 14%
• Immunogenicity 14%
• Inactivated Vaccine 14%
• ELISPOT 14%
• Booster Dose 14%